Mckesson Corporation
MCK
Market Cap$70.95B
Close$
Earnings Call Q3 2024
February 7, 2024 - AI Summary
McKesson reported solid financial performance in the third quarter of fiscal 2024, with total revenues of $80.9 billion and adjusted earnings per diluted share of $7.74, both growing by double-digits compared to the prior year.
The company raised and narrowed its guidance range for fiscal 2024 adjusted earnings per diluted share from $26.80-$27.40 to an updated range of $27.25-$27.65.
McKesson's U.S. pharmaceutical segment showed strong momentum, with adjusted operating profit growing 6% and volume increases across customer channels, including specialty pharmaceuticals and GLP-1 medications.
Exclusive for Stockcircle Pro members
Sign up
$725.19
36.5% upside
Current Fair Value
36.5% upsideUndervalued by 36.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $70.95 Billion |
|---|---|
| Enterprise Value | $74.86 Billion |
| Dividend Yield | $2.3971 (0.44%) |
| Earnings per Share | $22.11 |
| Beta | 0.0 |
| Outstanding Shares | 131,408,286 |
| Avg 30 Day Volume | 531,376 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 23.67 |
|---|---|
| PEG | -52.11 |
| Price to Sales | 0.23 |
| Price to Book Ratio | -33.19 |
| Enterprise Value to Revenue | 0.25 |
| Enterprise Value to EBIT | 19.28 |
| Enterprise Value to Net Income | 24 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | -2.87 |
Revenue Sources
No data
ESG Score
No data
About Mckesson Corporation
80,000 employees
CEO: Brian Tyler McKesson Corporation is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information solutions. McKesson partners with pharmaceutical manufacturers, p...